Gendron, Tania F.
van Blitterswijk, Marka
Bieniek, Kevin F.
Daughrity, Lillian M.
Jiang, Jie
Rush, Beth K.
Pedraza, Otto
Lucas, John A.
Murray, Melissa E.
Desaro, Pamela
Robertson, Amelia
Overstreet, Karen
Thomas, Colleen S.
Crook, Julia E.
Castanedes-Casey, Monica
Rousseau, Linda
Josephs, Keith A.
Parisi, Joseph E.
Knopman, David S.
Petersen, Ronald C.
Boeve, Bradley F.
Graff-Radford, Neill R.
Rademakers, Rosa
Lagier-Tourenne, Clotilde
Edbauer, Dieter
Cleveland, Don W.
Dickson, Dennis W.
Petrucelli, Leonard
Boylan, Kevin B.
Funding for this research was provided by:
National Institute of Neurological Disorders and Stroke (R21NS089979, R21NS089979, R21NS084528, R01NS088689, R01NS063964, R01NS077402, P01NS084974, P01NS084974, P01NS084974, P01NS084974, R01NS080882, F32NS087842)
U.S. Department of Defense (ALSRP AL130125)
Mayo Foundation for Medical Education and Research
Amyotrophic Lateral Sclerosis Association (15-IIP-202, Milton Safenowitz Post Doctoral Fellowship)
Target ALS
ALS Therapy Alliance
Ludwig Institute for Cancer Research
Seventh Framework Programme (FP7/2014-2019 grant 617198)
Robert Packard Center for ALS
Article History
Received: 20 July 2015
Revised: 29 August 2015
Accepted: 30 August 2015
First Online: 8 September 2015